So, we are of the view that an SNP of CYP19A1 gene was the independent risk factor of MetS‐BPH, and we speculate that the pathophysiological mechanism of MetS‐BPH was achieved by this gene's regulation of estrogen metabolism. Here, CYP19A1 is linked to benign prostatic hyperplasia.